Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $86.4300 (-1.54%) ($86.4300 - $88.3600) on Mon. Sep. 19, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.61% (three month average) | RSI | 32 | Latest Price | $86.4300(-1.54%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -1.8% a day on average for past five trading days. | Weekly Trend | LGND declines -2.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IWM(50%) IWN(49%) IWO(49%) IWC(47%) IBB(45%) | Factors Impacting LGND price | LGND will decline at least -1.305% in a week (0% probabilities). VXX(-16%) UUP(-16%) TBT(-8%) UNG(-7%) VIXM(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.305% (StdDev 2.61%) | Hourly BBV | -0.8 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $82.02(-5.1%) | Resistance Level | $94.41 | 5 Day Moving Average | $88.92(-2.8%) | 10 Day Moving Average | $91.38(-5.42%) | 20 Day Moving Average | $94.41(-8.45%) | To recent high | -19.7% | To recent low | 7.7% | Market Cap | $1.389b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |